Association between oral and general health related quality of life among Norwegian patients with substance use disorders in opioid agonist therapy

3Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: Assess the association between oral and general health related quality of life using oral impacts on daily performances (OIDP) and the quality of life tool EQ-5D-5L from EuroQoL among patients with substance use disorder (SUD) who receive opioid agonist therapy. Method: 609 patients with SUD completed the EQ-5D-5L. A dental sub-study of 167 patients completed OIDP and an oral examination when attending outpatient clinics in Western Norway for their opioid agonist therapy. The merged analytical sample consisted of 165 patients. The association between OIDP and EQ-5D-5L was assessed by Spearman’s rho and a linear multiple variable regression analysis. A line graph and a Pen’s parade displayed the distributions of OIDP sum scores and EQ-5D-5L index values. Results: Overall mean summary- and index EQ-5D-5L scores were 9.97 (sd 3.25) and 0.69 (sd 0.22). Mean score for OIDP was 9.75 (sd 9.59). Spearman’s rho was 0.34 (p

Cite

CITATION STYLE

APA

Åstrøm, A. N., Vold, J. H., Aas, C. F., Johansson, K. A., & Fadnes, L. T. (2023). Association between oral and general health related quality of life among Norwegian patients with substance use disorders in opioid agonist therapy. Acta Odontologica Scandinavica, 81(4), 332–339. https://doi.org/10.1080/00016357.2022.2153736

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free